Bostwick, D. G., Wilk, M. M., Bostwick, B. R., Rydesky, P. M., Littrup, P. J., Cribbs, M., . . . Qian, J. (2023). 706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial). BMJ Publishing Group.
Цитирование в стиле Чикаго (17-е изд.)Bostwick, David G., et al. 706 First-in-human Phase 2 Clinical Trial of Multiplex Combination Intratumoral Immunotherapy (MCII) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial). BMJ Publishing Group, 2023.
Цитирование MLA (9-е изд.)Bostwick, David G., et al. 706 First-in-human Phase 2 Clinical Trial of Multiplex Combination Intratumoral Immunotherapy (MCII) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial). BMJ Publishing Group, 2023.